Ranivisio 10 mg/ml, Injektionslösung in einer Fertigspritze

7680704120018 CH-70412 Injektionslösung

Associated product:

RANIVISIO Sol inj 1.65 mg/0.165ml ser préremp 1pce

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ranibizumabum
10.0 MG Substance Wirkstoff (Principe actif)
trehalosum dihydricum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
histidinum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Bioeq AG

6300 Zug

Authorization information

Swissmedic authorization number
70412
Drug name
Ranivisio, Injektionslösung in einer Fertigspritze
Galenic form
LSINJ
ATC Code
S01LA04
Authorization status
Z
Dispensing category
B
First authorization
19/12/2025
Authorization expiration date
18/12/2030
IT Number
11.99.0.
Domain
Human medicine
Field of application
exsudative altersbezogene Makuladegeneration, Visusverlust duch diabetisches Makulaödem, durch Makulaödem infolge eines retinalen Venenverschlusses und durch choroidale Neovaskularisation infolge pathologischer Myopie, aktive, den Visus beeinträchtigende choroidale Neovaskularisation, mässig schwere bis schwere NPDR bzw PDR

Package details

Description (FR)
RANIVISIO Sol inj 1.65 mg/0.165ml ser préremp 1pce
Description (DE)
RANIVISIO Inj Lös 1.65 mg/0.165ml Fertspr 1Stk
Market launch
01/11/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data